![]() |
| Node Negative Early Stage Breast Cancer Patients Benefit Fr |
|
RSS FEED
|
Sanofi-aventis and GEICAM (Grupo Espanol de Investigacion en Cancer de Mama) announced that for women with high-risk node-negative early stage breast cancer adjuvant treatment (post surgery) with Taxotere(R) (docetaxel) Injection Concentrate as part of the TAC regimen (Taxotere(R), dox
Read more... |
||||||||||||
|
|
|||||||||||||
| Node Negative Early Stage Breast Cancer Patients Benefit Fr |
|
||
|
Site Map
|
Sitemap |
